Avadel Pharmaceuticals PLC at Ladenburg Thalmann Healthcare Conference Transcript
My name's [Raymond], and I'm part of the health care research team at Ladenburg Thalmann. And it's my pleasure to welcome Avadel Pharmaceuticals, so.
Thank you, [Raymond]. Good afternoon, everyone. We certainly appreciate the opportunity from Ladenburg to be here and to present, and to give an update on the company. We've had a, what I would characterize as a pretty busy 24 hours with some of our news we announced just yesterday. But a very busy last 9 or 10 months as we've really worked hard to reposition the company in a new go-forward strategy.
During the course of the next few minutes, I would like to spend some time and tell you a little bit about what we've been up to, what we've worked on and what we've accomplished over the last 9 or -- 8, 9, 10 months, spend a little bit of time on our FT218 program and then wrap up a little bit in terms of some key milestones for the balance of this year. And then of course, we'll answer questions. I'm here with Dr. Jordan Dubow,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
